Presents questions and answers pertaining to Medicare in the United States. Coverage of digital rectal exams and prostate-specific antigen tests; Information on the HCFA 1500 claim form; Documentation for a B-12...
(ie, not diagnostic) procedure codes; only patients aged ≥85 y PSA testing for men aged ≥75 y USPSTF PSA test for patients aged ≥75 y No history of prostate cancer;only screening (ie, not diagnostic) procedure codes Diagnostic and Preventive Testing Bone mineral density testing at ...
The Relationship Between Education and Prostate-Specific Antigen Testing Among Urban African American Medicare Beneficiaries Purpose We examined the association between socioeconomic status (SES) and prostate-specific antigen (PSA) cancer screening among older African American me... MK Hararah,CE Pollack,...
Gustafsonsaid “Well, in a nutshell, we're running out of money and that ought to scare us all. As a nation we have no plan for dealing with that problem. What I'm talking about is the exhaustion of the Medicare party trust fund; that's only part of the funding for Medicare but t...
The Galleri test requires a prescription from a licensed healthcare provider and should be used in addition to recommended cancer screenings such as mammography, colonoscopy, prostate-specific antigen (PSA) test, or cervical cancer screeni...
Early screening of men for PSA may serve to stratify the male population by risk of future clinical prostate cancer.Case-control study nested within the Danish 'Diet, Cancer and Health' cohort of 27,179 men aged 50-64 at enrolment. PSA measured in serum collected at cohort entry in 1993-...
Several questions and answers on non-screening Prostate-Specific Antigen (PSA) covered by medicare are presented including one on checking PSA in a patient on testosterone therapy, pre-authorization for ...
[1] In the cross-sectional study, which included nearly 1 million men aged 70 years or older without preexisting prostate cancer conditions who were enrolled in a Medicare Advantage plan between 2016 and 2018, investigators found that 38.6% of enrollees received a low-value PSA cancer screening...
in the October 4, 2013 issue of "Cancer," showing that the cost of prostate-specific antigen (PSA) screening and downstream processes among male Medicare beneficiaries aged 65 years above advances 500 million dollars yearly.doi:10.1007/s40274-013-0833-4...
Although prostate cancer-specific mortality is probably reduced, the all-cause mortality benefit of aggressive prostate cancer treatment is unproven and probably small at best. There is a substantial negative impact of treatment on men9s quality of life. As a result, PSA screening should be ...